Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Evotec
Evotec
Activities:
Research & Development
Cleaning
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
N4 Pharma and SRI to target and treat previously unreachable human cells
The companies will collaborate to perform research to conjugate SRI’s MGS system to Nuvec to increase intracellular delivery to specific target cells.
Berry Global invests to increase production capacity for healthcare products
Berry Global Group has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
Titian and Evotec sign three-year agreement for sample management platform
The two companies have entered into an agreement that means Titian's software user licences can enable rapid deployment across new Evotec stites
Pharmaceutical
Evotec agrees to give US Merck access to facility of the future
MSD has paid $15m to gain access to Just–Evotec Biologics’ J.POD Washington facility that conducts small, intensified bioprocessing operations housed inside autonomous cleanrooms
Finance
Evotec acquires US biotech Just Biotherapeutics for $90 million
The US$90 million for the German company to make the acquisition includes the potential performance-based earn-out components expected within the next three years
Research & Development
Pharma giants join £9.5 million dementia drug discovery collaboration
Johnson & Johnson Innovation, Takeda and Evotec have joined The Dementia Consortium
Research & Development
Galapagos expands fibrosis portfolio
Fibrosis small molecule programme has been announced as the focus of a partnership between Galapagos and Evotec
Research & Development
Evotec and ABIVAX collaborate to develop novel antiviral agents
Evotec and ABIVAX have announced a strategic collaboration to discover and develop novel treatments for multiple viral infectious diseases
Media
Evotec to acquire Aptuit, expanding leadership in external innovation
Evotec and Aptuit have entered into a definitive agreement, Evotec will acquire Aptuit for US$ 300 million
Subscribe now